Testing Information

Testing Status of Agents at NTP

Tolazamide

Print this pageFriendly URL

http://ntp.niehs.nih.gov/go/TS-10928-E

CASRN: 1156-19-0

Formula: C14 H21 N3 O3 S

Synonyms/Common Names:

  • N-(((HEXAHYDRO-1H-AZEPIN-1-YL)AMINO)CARBONYL)-4-METHYL-BENZENESULFONAMIDE (9CI)

Known Uses:

HYPOGLYCEMIC AGENT

Short-Term Toxicity

  • 14-Day (Dosed-Feed)  (C03327) Completed 
    • NTIS No. PB284610  (Peer Review 03/06/1978)
      Citation: Bioassay of Tolazamide for Possible Carcinogenicity (CAS No. 1156-19-0)
    • Rats: F344/N; Mice: B6C3F1
  • 13-Week (Dosed-Feed)  (C03327) Completed 
    • NTIS No. PB284610  (Peer Review 03/06/1978)
      Citation: Bioassay of Tolazamide for Possible Carcinogenicity (CAS No. 1156-19-0)
    • Rats: F344/N; Mice: B6C3F1
    • Dose: FR: 0,2500,40000, FM: 0,2000,50000 PPM/5 PER GROUP

Long-Term Carcinogenicity

  • 2-Year (Dosed-Feed)  (C03327) Report Complete 
    • TR-051 (NTIS No. PB284610)  (Peer Review 03/06/1978)
      Bioassay of Tolazamide for Possible Carcinogenicity (CAS No. 1156-19-0)
    • Rats: F344/N; Mice: B6C3F1
    • Carcinogenesis Results
      • Male Rats Negative 
      • Female Rats Negative 
      • Male Mice Negative 
      • Female Mice Negative 
    • Dose: 0,5000,10000 PPM/35 PER GROUP

Genetic Toxicology

  • In Vitro Cytogenetics (CA/SCE)  (225955) Completed 
    • Chromosome Aberation Negative 
    • Sister Chromatid Exchange Negative 
  • Mouse Lymphoma  (255587) Completed 
    •  Negative 
  • Salmonella  (352518) Completed 
    • Citation: Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. Salmonella mutagenicity tests. IV. Results from the testing of 300 chemicals Environ. Molec. Mutagen. Vol. 11 (Suppl 12) (1988) 1-158
    •  Inconclusive